Literature DB >> 33987898

Beyond Photo: Xdynamic Therapies in Fighting Cancer.

Sheng Wang1, Rui Tian2, Xu Zhang1, Guohui Cheng1, Peng Yu1, Jin Chang1, Xiaoyuan Chen3,4,5,6.   

Abstract

Reactive oxygen species (ROS)-related therapeutic approaches are developed as a promising modality for cancer treatment because the aberrant increase of intracellular ROS level can cause cell death due to nonspecific oxidation damage to key cellular biomolecules. However, the most widely considered strategy, photodynamic therapy (PDT), suffers from critical limitations such as limited tissue-penetration depth, high oxygen dependence, and phototoxicity. Non-photo-induced ROS generation strategies, which are defined as Xdynamic therapies (X = sono, radio, microwave, chemo, thermo, and electro), show good potential to overcome the drawbacks of PDT. Herein, recent advances in the development of Xdynamic therapies, including the design of systems, the working mechanisms, and examples of cancer therapy application, are introduced. Furthermore, the approaches to enhance treatment efficiency of Xdynamic therapy are highlighted. Finally, the perspectives and challenges of these strategies are also discussed.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  Xdynamic therapy; cancer; enhanced therapy; nanotechnology; reactive oxygen species

Mesh:

Substances:

Year:  2021        PMID: 33987898     DOI: 10.1002/adma.202007488

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  6 in total

1.  Sequence-Activated Fluorescent Nanotheranostics for Real-Time Profiling Pancreatic Cancer.

Authors:  Yining Tao; Chenxu Yan; Dan Li; Jianfeng Dai; Yingsheng Cheng; Hui Li; Wei-Hong Zhu; Zhiqian Guo
Journal:  JACS Au       Date:  2022-01-10

2.  Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy.

Authors:  Yuxuan Xiong; Zibing Wang; Qiang Wang; Qingyuan Deng; Jitang Chen; Jianshuang Wei; Xiaoquan Yang; Xiangliang Yang; Zifu Li
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

3.  Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress.

Authors:  Tingting Zhang; Chenxin Xu; Peisen Zheng; Xiaoxian Zhang; Chenyu Qiu; Fengjiao Wu; Jundixia Chen; Zhongxiang Xiao; Jiandong Zhu; Jingjing Zhang; Peng Zou; Daoyong Ni
Journal:  Oxid Med Cell Longev       Date:  2022-02-25       Impact factor: 6.543

Review 4.  Solar Energy Catalysis.

Authors:  Xiaodong Sun; Shuaiyu Jiang; Hongwei Huang; Hui Li; Baohua Jia; Tianyi Ma
Journal:  Angew Chem Int Ed Engl       Date:  2022-05-31       Impact factor: 16.823

5.  Near-infrared phosphorescent carbon dots for sonodynamic precision tumor therapy.

Authors:  Bijiang Geng; Jinyan Hu; Yuan Li; Shini Feng; Dengyu Pan; Lingyan Feng; Longxiang Shen
Journal:  Nat Commun       Date:  2022-09-30       Impact factor: 17.694

Review 6.  Rational Nanomedicine Design Enhances Clinically Physical Treatment-Inspired or Combined Immunotherapy.

Authors:  Qiaoqiao Liu; Wei Zhang; Rong Jiao; Zheng Lv; Xia Lin; Yunping Xiao; Kun Zhang
Journal:  Adv Sci (Weinh)       Date:  2022-08-24       Impact factor: 17.521

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.